Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
- PMID: 25825723
- PMCID: PMC4418866
- DOI: 10.1073/pnas.1421961112
Zinc as chaperone-mimicking agent for retardation of amyloid β peptide fibril formation
Abstract
Metal ions have emerged to play a key role in the aggregation process of amyloid β (Aβ) peptide that is closely related to the pathogenesis of Alzheimer's disease. A detailed understanding of the underlying mechanistic process of peptide-metal interactions, however, has been challenging to obtain. By applying a combination of NMR relaxation dispersion and fluorescence kinetics methods we have investigated quantitatively the thermodynamic Aβ-Zn(2+) binding features as well as how Zn(2+) modulates the nucleation mechanism of the aggregation process. Our results show that, under near-physiological conditions, substoichiometric amounts of Zn(2+) effectively retard the generation of amyloid fibrils. A global kinetic profile analysis reveals that in the absence of zinc Aβ40 aggregation is driven by a monomer-dependent secondary nucleation process in addition to fibril-end elongation. In the presence of Zn(2+), the elongation rate is reduced, resulting in reduction of the aggregation rate, but not a complete inhibition of amyloid formation. We show that Zn(2+) transiently binds to residues in the N terminus of the monomeric peptide. A thermodynamic analysis supports a model where the N terminus is folded around the Zn(2+) ion, forming a marginally stable, short-lived folded Aβ40 species. This conformation is highly dynamic and only a few percent of the peptide molecules adopt this structure at any given time point. Our findings suggest that the folded Aβ40-Zn(2+) complex modulates the fibril ends, where elongation takes place, which efficiently retards fibril formation. In this conceptual framework we propose that zinc adopts the role of a minimal antiaggregation chaperone for Aβ40.
Keywords: Alzheimer’s disease; NMR relaxation; aggregation kinetics; amyloid beta peptide; zinc ion interactions.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Comment in
-
Preventing peptide and protein misbehavior.Proc Natl Acad Sci U S A. 2015 Apr 28;112(17):5267-8. doi: 10.1073/pnas.1505170112. Epub 2015 Apr 20. Proc Natl Acad Sci U S A. 2015. PMID: 25902542 Free PMC article. No abstract available.
Similar articles
-
Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.Acc Chem Res. 2023 Oct 3;56(19):2653-2663. doi: 10.1021/acs.accounts.3c00370. Epub 2023 Sep 21. Acc Chem Res. 2023. PMID: 37733746 Free PMC article.
-
Dynamics of Zn(II) binding as a key feature in the formation of amyloid fibrils by Aβ11-28.Inorg Chem. 2012 Jan 2;51(1):701-8. doi: 10.1021/ic202247m. Epub 2011 Dec 13. Inorg Chem. 2012. PMID: 22148916
-
Surface plasmon resonance imaging of amyloid-β aggregation kinetics in the presence of epigallocatechin gallate and metals.Anal Chem. 2013 Feb 19;85(4):2049-55. doi: 10.1021/ac303181q. Epub 2013 Jan 29. Anal Chem. 2013. PMID: 23276205
-
In vitro oligomerization and fibrillogenesis of amyloid-beta peptides.Subcell Biochem. 2012;65:53-74. doi: 10.1007/978-94-007-5416-4_3. Subcell Biochem. 2012. PMID: 23224999 Review.
-
Role of metal ions in the self-assembly of the Alzheimer's amyloid-β peptide.Inorg Chem. 2013 Nov 4;52(21):12193-206. doi: 10.1021/ic4003059. Epub 2013 Apr 22. Inorg Chem. 2013. PMID: 23607830 Review.
Cited by
-
Copper(II) Can Kinetically Trap Arctic and Italian Amyloid-β40 as Toxic Oligomers, Mimicking Cu(II) Binding to Wild-Type Amyloid-β42: Implications for Familial Alzheimer's Disease.JACS Au. 2024 Feb 6;4(2):578-591. doi: 10.1021/jacsau.3c00687. eCollection 2024 Feb 26. JACS Au. 2024. PMID: 38425915 Free PMC article.
-
Extracellular Vesicles Slow Down Aβ(1-42) Aggregation by Interfering with the Amyloid Fibril Elongation Step.ACS Chem Neurosci. 2024 Mar 6;15(5):944-954. doi: 10.1021/acschemneuro.3c00655. Epub 2024 Feb 26. ACS Chem Neurosci. 2024. PMID: 38408014 Free PMC article.
-
Analysis of the potential and mechanism of Ginkgo biloba in the treatment of Alzheimer's disease based on network pharmacology.Ibrain. 2021 Mar 28;7(1):21-28. doi: 10.1002/j.2769-2795.2021.tb00060.x. eCollection 2021 Mar. Ibrain. 2021. PMID: 37786872 Free PMC article.
-
Metal Binding of Alzheimer's Amyloid-β and Its Effect on Peptide Self-Assembly.Acc Chem Res. 2023 Oct 3;56(19):2653-2663. doi: 10.1021/acs.accounts.3c00370. Epub 2023 Sep 21. Acc Chem Res. 2023. PMID: 37733746 Free PMC article.
-
Short hydrophobic loop motifs in BRICHOS domains determine chaperone activity against amorphous protein aggregation but not against amyloid formation.Commun Biol. 2023 May 8;6(1):497. doi: 10.1038/s42003-023-04883-2. Commun Biol. 2023. PMID: 37156997 Free PMC article.
References
-
- Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006;75:333–366. - PubMed
-
- Benilova I, De Strooper B. An overlooked neurotoxic species in Alzheimer’s disease. Nat Neurosci. 2011;14(8):949–950. - PubMed
-
- Haass C, Selkoe DJ. Soluble protein oligomers in neurodegeneration: Lessons from the Alzheimer’s amyloid beta-peptide. Nat Rev Mol Cell Biol. 2007;8(2):101–112. - PubMed
-
- Bush AI, et al. Rapid induction of Alzheimer A beta amyloid formation by zinc. Science. 1994;265(5177):1464–1467. - PubMed
-
- Ayton S, Lei P, Bush AI. Metallostasis in Alzheimer’s disease. Free Radic Biol Med. 2013;62:76–89. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
